Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cara Therapeutics (CARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 700,000
  • Shares Outstanding, K 39,548
  • Annual Sales, $ 13,470 K
  • Annual Income, $ -74,010 K
  • 60-Month Beta 2.70
  • Price/Sales 53.26
  • Price/Cash Flow N/A
  • Price/Book 5.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.55
  • Number of Estimates 6
  • High Estimate -0.38
  • Low Estimate -0.71
  • Prior Year -0.51
  • Growth Rate Est. (year over year) -7.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.32 +9.18%
on 04/18/19
20.85 -9.30%
on 04/08/19
+0.61 (+3.33%)
since 03/22/19
3-Month
14.10 +34.11%
on 01/29/19
20.85 -9.30%
on 04/08/19
+3.89 (+25.90%)
since 01/23/19
52-Week
11.50 +64.43%
on 05/10/18
24.30 -22.18%
on 09/21/18
+6.55 (+52.99%)
since 04/23/18

Most Recent Stories

More News
Cara Therapeutic Shares Up 12.8% Since SmarTrend's Buy Recommendation (CARA)

SmarTrend identified an Uptrend for Cara Therapeutic (NASDAQ:CARA) on January 7th, 2019 at $15.66. In approximately 3 months, Cara Therapeutic has returned 12.81% as of today's recent price of $17.66....

CARA : 18.91 (+6.84%)
Cara Therapeutic Set to Possibly Pullback After Yesterday's Rally of 1.68%

Cara Therapeutic (NASDAQ:CARA) traded in a range yesterday that spanned from a low of $19.90 to a high of $20.79. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high...

CARA : 18.91 (+6.84%)
Cara Therapeutics to Present at the 18th Annual Needham Healthcare Conference

Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on the treatment of pruritus by selectively targeting...

CARA : 18.91 (+6.84%)
Analysis: Positioning to Benefit within American Water Works, TripAdvisor, ACADIA Pharmaceuticals, Dril-Quip, Domtar, and Cara Therapeutics -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of American Water Works Company,...

TRIP : 53.61 (+3.37%)
DRQ : 46.45 (+0.41%)
CARA : 18.91 (+6.84%)
UFS : 48.63 (+2.25%)
AWK : 104.80 (-0.12%)
ACAD : 24.37 (+2.65%)
Uptrend Call Working As Cara Therapeutic Stock Rises 25.5% (CARA)

SmarTrend identified an Uptrend for Cara Therapeutic (NASDAQ:CARA) on January 7th, 2019 at $15.66. In approximately 2 months, Cara Therapeutic has returned 25.46% as of today's recent price of $19.64....

CARA : 18.91 (+6.84%)
Uptrend Call Working As Cara Therapeutic Stock Rises 23.6% (CARA)

SmarTrend identified an Uptrend for Cara Therapeutic (NASDAQ:CARA) on January 7th, 2019 at $15.66. In approximately 2 months, Cara Therapeutic has returned 23.60% as of today's recent price of $19.35....

CARA : 18.91 (+6.84%)
Watch for Cara Therapeutic to Potentially Pullback After Gaining 11.42% Yesterday

Cara Therapeutic (NASDAQ:CARA) traded in a range yesterday that spanned from a low of $19.42 to a high of $19.53. Yesterday, the shares gained 11.4%, which took the trading range above the 3-day high...

CARA : 18.91 (+6.84%)
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates

Cara (CARA) delivered earnings and revenue surprises of 11.86% and 65.26%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

CARA : 18.91 (+6.84%)
Cara: 4Q Earnings Snapshot

STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Tuesday reported a loss of $20.7 million in its fourth quarter.

CARA : 18.91 (+6.84%)
Cara Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus as well as pain by selectively targeting...

CARA : 18.91 (+6.84%)
GNHAF : 123.9861 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade CARA with:

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Key Turning Points

2nd Resistance Point 20.04
1st Resistance Point 19.47
Last Price 18.91
1st Support Level 18.02
2nd Support Level 17.14

See More

52-Week High 24.30
Fibonacci 61.8% 19.41
Last Price 18.91
Fibonacci 50% 17.90
Fibonacci 38.2% 16.39
52-Week Low 11.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar